JOHN FOREYT to Placebos
This is a "connection" page, showing publications JOHN FOREYT has written about Placebos.
Connection Strength
0.103
-
Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial. Diabetes Care. 2014 Dec; 37(12):3227-34.
Score: 0.054
-
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
Score: 0.020
-
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2609-18.
Score: 0.018
-
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care. 2002 Jul; 25(7):1123-8.
Score: 0.012